PITX1 and colonic neoplasm: A clinicopathologic study revealed that approximately 50% of colon cancer patients had reduced expression of PITX1, and a significant correlation was observed between the low expression of PITX1 and shorter prognosis, worse staging, and more positive lymph node metastasis in colon cancer patients (29).